Aleafia Health Inc. has entered into a definitive three-year cannabis supply agreement (the Supply Agreement) with Apipharm Veletrgovina d.o.o. (Apipharm). Apipharm specializes in the distribution of active pharmaceutical ingredients of plant origin including semi-synthetic cannabinoid isolates, along with the development of advanced pharmaceutical formulations. Under the terms of the agreement, Aleafia Health will supply Apipharm with dried cannabis flower grown at its Niagara greenhouse facility. Apipharm has also submitted an initial purchase order to Aleafia Health, for 1,000 kg of premium dried flower. The initial purchase order is expected to ship as early as the end of First Quarter 2021, dependent on the timing of necessary import and export permits.